Market Place
Sourcing Support
European Commission Approves Yuvanci For PAH
30 Sep 2024 //
GLOBENEWSWIRE
Torrent`s Generics Macitentan Receives Approval in US
05 Aug 2024 //
FDA
J&J Receives Positive CHMP Opinion For Yuvanci In PAH Treatment
26 Jul 2024 //
GLOBENEWSWIRE
FDA approves Johnson & Johnson`s combo pill Opsynvi for PAH
26 Mar 2024 //
FIERCE PHARMA
FDA Approves OPSYNVI® (macitentan and tadalafil) for Patients with PAH
22 Mar 2024 //
PR NEWSWIRE
Apotex`s Generic Macitentan Receives Approval in the U.S.
09 Jan 2024 //
FDA
Janssen Submits MAA to EMA Seeking Approval of STCT of Macitentan & Tadalafil
26 Jun 2023 //
GLOBENEWSWIRE
Janssen Submits NDA to FDA Seeking Approval of Invg Single Tab ComboTherapy
30 May 2023 //
PR NEWSWIRE
In PAH patients, J&J`s combo pill Opsynvi increases blood flow
07 Mar 2023 //
FIERCE PHARMA
Phase 3 A DUE Data Show Tablet Combination Therapy of Macitentan & Tadalafil
06 Mar 2023 //
PR NEWSWIRE
RHODES` Generic Macitentan Receives Approval in the U.S.
11 Jan 2023 //
FDA
Alembic gets US FDA tentative nod for macitentan tablets
14 Mar 2022 //
PHARMABIZ
Zydus Pharms`s Generic Macitentan Receives Approval In US
10 Apr 2021 //
FDA
TRITON Phase 3b Study Results Presented at the European Society of Cardiology
31 Aug 2020 //
BUSINESSWIRE
Seasons Biotechnology (Taizhou) Generic Macitentan Receive Approval in U.S
16 Apr 2020 //
FDA
New OPSUMIT® (macitentan) Data Show Initial Combination Therapy with Tadalafil
21 Oct 2019 //
PR NEWSWIRE
J&J unit to pay $360 million to U.S. to resolve charity kickback probe
07 Dec 2018 //
REUTERS
Actelion`s Opsumit (macitentan) Receives Marketing Approval in EU
04 Oct 2018 //
EMA
Nautic Partners Announces Acquisition of Mikart, Inc.; Michael Kallelis as CEO
27 Sep 2018 //
BUSINESSWIRE
Actelion’s Opsumit shows promise in portopulmonary hypertension
19 Sep 2018 //
PHARMA TIMES
First RCT in Pulm. Htn Shows macitentan Improves Pulmonary Vascular Resistance
17 Sep 2018 //
BUSINESSWIRE
FDA tries to shame drugmakers over tactics that delay generics
18 May 2018 //
FIERCE PHARMA
FDA ‘names and shames’ generic-blocking pharma companies
17 May 2018 //
PMLIVE
Actelion Submits sNDA to US FDA Seeking Approval of OPSUMIT® (macitentan)
30 Apr 2018 //
PR NEWSWIRE
Opsumit (Macitentan): Actelion Pharmaceuticals v. Zydus Pharmaceuticals (USA)
31 Jan 2018 //
PATENT LITIGATION
FDA Confirms Paragraph IV Patent Challenge of Opsumit (Macitentan)Tablets
08 Dec 2017 //
FDA
Johnson & Johnson May Never Recoup Its Costs to Buy Actelion
28 Jan 2017 //
MOTLEY FOOL
Key J&J meds disappoint in Q4, triggering a top-line miss
25 Jan 2017 //
FIERCE PHARMA
Actelion Fails Key PhIII, but Investors Brush it off as J&J Megadeal Draws Near
24 Jan 2017 //
FIERCE PHARMA
J&J Discussing Breaking up Actelion in an Acquisition
30 Dec 2016 //
REUTERS
Payer Squeeze Prompts Sanofi to Slash 20% of U.S. Diabetes Sales Force
12 Dec 2016 //
FIERCE PHARMA
Actelion`s ambitious independent-minded CEO will drive up takeover price
28 Nov 2016 //
REUTERS
Actelion hikes core profit guidance after strong first-half
21 Jul 2016 //
REUTERS
Swiss drugmaker Actelion forecasts earnings growth in 2016
09 Feb 2016 //
REUTERS
Actelion says selexipag to enter U.S. market in January
22 Dec 2015 //
REUTERS
With FDA nod, Actelion adds blockbuster hopeful Uptravi to PAH portfolio
22 Dec 2015 //
FIERCE PHARMA
GSK earns expanded approval for Volibris in Europe
26 Nov 2015 //
PM LIVE
Gilead and GSK pulmonary hypertension drugs work in tandem
28 Aug 2015 //
PM LIVE
DKSH signs agreement with Actelion to drive growth in Asia
12 Aug 2015 //
PBR
Actelion`s Opsumit growth heralds smooth switch off aging Tracleer
21 Jul 2015 //
FIERCE PHARMA
